evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract,articles/19/pmid,articles/19/title,articles/19/journal,articles/19/pubDate,articles/19/volume,articles/19/issue,articles/19/pages,articles/19/authors,articles/19/elocationId,articles/19/link,articles/19/reference,articles/19/abstract,articles/20/pmid,articles/20/title,articles/20/journal,articles/20/pubDate,articles/20/volume,articles/20/issue,articles/20/pages,articles/20/authors,articles/20/elocationId,articles/20/link,articles/20/reference,articles/20/abstract,articles/21/pmid,articles/21/title,articles/21/journal,articles/21/pubDate,articles/21/volume,articles/21/issue,articles/21/pages,articles/21/authors,articles/21/elocationId,articles/21/link,articles/21/reference,articles/21/abstract,articles/22/pmid,articles/22/title,articles/22/journal,articles/22/pubDate,articles/22/volume,articles/22/issue,articles/22/pages,articles/22/authors,articles/22/elocationId,articles/22/link,articles/22/reference,articles/22/abstract
19597,GENE_BACKGROUND,,"EIF4E (eukaryotic translation initiation factor 4E ) is located on chromosome 4q23 and encodes a member of the eukaryotic translation initiation factor 4F (eIF4F) complex. The eIF4F complex additionally consists of an EIF4A isoform and EIF4G and directs the ribosome to the 5' 7-methylguanosine cap of mRNAs in what is considered a rate-limiting step of translation (PMID: 291969, 3469651). As a vital part of translation initiation, EIF4E controls cellular size and in that context is thought to be an direct target of mTOR which can phosphorylate the translational repressor 4EBP1, which allows for EIF4E to enter the eIF4F complex (PMID: 12080086). Overexpression of EIF4E has been detected in tumors of the breast, bladder, colon, lung, and cervix and can cause malignant transformation in in vitro studies (PMID: 9330633, 9285563, 8244582, 7829225, 25986608, 10638984, 11401917, 12374671, 16260273, 16280668, 20049173). Furthermore, EIF4E exhibits oncogenic traits in a mouse-model of lymphoma and is implicated in drug resistance both in contexts of mTOR, BRAF, and MEK targeting (PMID: 15029198, 16103051, 25079330, 25422161, 25615552). Thusly, EIF4E is considered a therapeutical target in certain tumor types on the principles that translational control often is deregulated in cancer cells and that PI3K and mTOR signaling and MAPK-interacting kinases (MNKs) are involved in this process (PMID: 22474009, 25743081, 25425688). A variant in the promoter region of EIF4E has been identified in two families with autistic children (PMID: 19556253).",,2017-01-09,,1977,EIF4E,eukaryotic translation initiation factor 4E,False,ENST00000280892,NM_001130678.1,CBP,eIF-4E,EIF4EL1,EIF4F,AUTS19,EIF4E1,False,22474009,Emerging therapeutics targeting mRNA translation.,Cold Spring Harbor perspectives in biology,2018-04-01T20:12:00,4,4,a012377,Malina A et al,doi: 10.1101/cshperspect.a012377,,0001-04-01,,16103051,Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.,Cancer research,2018-08-15T20:05:00,65,16,7052-8,0001-01-07,,,0001-08-15,,9285563,Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas.,Oncogene,0001-08-28,15,9,1087-94,Nathan CO et al,,,0001-08-28,,15029198,Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.,Nature,2018-03-18T20:04:00,428,6980,332-7,Wendel HG et al,,,0001-03-18,,16260273,eIF-4E expression is associated with histopathologic grades in cervical neoplasia.,Human pathology,2018-11-01T20:05:00,36,11,1197-203,Lee JW et al,,,2018-11-01T02:03:00,,12080086,Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.,Genes &amp; development,2018-06-15T20:02:00,16,12,1472-87,Fingar DC et al,,,0001-06-15,,25079330,eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.,Nature,2018-09-04T20:14:00,513,7516,105-9,Boussemart L et al,doi: 10.1038/nature13572,,0001-09-04,,9330633,Assignment of the human gene encoding eukaryotic initiation factor 4E (EIF4E) to the region q21-25 on chromosome 4.,Somatic cell and molecular genetics,0001-05-01,23,3,221-3,Jones RM et al,,,0001-05-01,,10638984,Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.,British journal of cancer,2018-01-01T20:00:00,82,True,161-6,Crew JP et al,,,0001-01-01,,11401917,Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.,"Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",2018-06-01T20:01:00,10,6,663-6,Berkel HJ et al,,,0001-06-01,,25743081,Targeting the translation machinery in cancer.,Nature reviews. Drug discovery,2018-04-01T20:15:00,14,4,261-78,Bhat M et al,doi: 10.1038/nrd4505,,0001-04-01,,16280668,eIF4E as a marker for cervical neoplasia.,Applied immunohistochemistry &amp; molecular morphology : AIMM,2017-12-01T20:05:00,13,4,367-70,Matthews-Greer J et al,,,0001-12-01,,12374671,Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-10-01T20:02:00,8,10,3046-53,Seki N et al,,,0001-10-01,,7829225,Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts.,International journal of cancer,0001-01-17,60,2,255-63,Graff JR et al,,,0001-01-17,,25615552,The role of eIF4E in response and acquired resistance to vemurafenib in melanoma.,The Journal of investigative dermatology,2018-05-01T20:15:00,135,5,1368-1376,Zhan Y et al,doi: 10.1038/jid.2015.11,,0001-05-01,,19556253,Deregulation of EIF4E: a novel mechanism for autism.,Journal of medical genetics,2018-11-01T20:09:00,46,11,759-65,Neves-Pereira M et al,doi: 10.1136/jmg.2009.066852,,0001-11-01,,25986608,Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor Î² Early Protransforming Events in Breast Epithelial Cells.,Molecular and cellular biology,2018-08-01T20:15:00,35,15,2597-609,Decarlo L et al,doi: 10.1128/MCB.00324-15,,2018-08-01T06:09:00,,25422161,Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E.,International journal of oncology,2018-02-01T20:15:00,46,2,860-70,Zismanov V et al,doi: 10.3892/ijo.2014.2774,,0001-02-01,,291969,Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP.,Proceedings of the National Academy of Sciences of the United States of America,0001-09-01,76,9,4345-9,Sonenberg N et al,,,0001-09-01,,25425688,A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E.,Haematologica,2018-01-01T20:15:00,100,True,e7-9,Assouline S et al,doi: 10.3324/haematol.2014.111245,,0001-01-01,,3469651,Amino acid sequence of the mRNA cap-binding protein from human tissues.,Proceedings of the National Academy of Sciences of the United States of America,0001-02-01,84,4,945-9,Rychlik W et al,,,0001-02-01,,8244582,Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts.,International journal of cancer,0001-11-11,55,5,841-7,Rinker-Schaeffer CW et al,,,0001-11-11,,20049173,Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.,Journal of oncology,2009,2009,,981679,Culjkovic B et al,doi: 10.1155/2009/981679,,Culjkovic B et al. Journal of oncology. 2009;2009()981679.,
19596,GENE_SUMMARY,,EIF4E is a translation initiation factor with an essential role in control of translation. EIF4E is overexpressed in multiple tumor types and is considered a potential therapeutic target.,,2017-01-09,,1977,EIF4E,eukaryotic translation initiation factor 4E,False,ENST00000280892,NM_001130678.1,CBP,eIF-4E,EIF4EL1,EIF4F,AUTS19,EIF4E1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
